On Dec. 23, 2024, the U.S. Court of Appeals for the Fifth Circuit granted the government’s emergency motion for a stay of a District Court’s nationwide preliminary injunction against enforcement of the Corporate Transparency Act (CTA). The appellate court’s unpublished order in Texas Top Cop Shop v. Garland reinstates the act, which has a year-end
Healthcare & Life Sciences Private Equity Deal Tracker: Heritage Group Invests in Nationwide Medical
Heritage Group has invested in Nationwide Medical, according to a news release.
Nationwide, founded in 2002 and based in Calabasas, California, is a provider of home medical equipment and clinical services for patients with chronic sleep and respiratory conditions.
Heritage Group, founded in 1986 and based in Nashville, Tenn., makes control and…
North Carolina Supreme Court Unlocks the Door to COVID-19 Business Interruption Coverage, Holding that Pandemic-Era Restrictions on Use of Property Constitute “Direct Physical Loss” to Property
Last week, the North Carolina Supreme Court issued its long-awaited ruling in North State Deli, LLC v. The Cincinnati Insurance Company, siding with a group of North Carolina restaurants that sought business interruption insurance for losses they sustained because of the COVID-19 pandemic. Specifically, the court held that those restaurants sustained “direct physical loss” to property, as that phrase is used in their commercial property policies, when COVID-19 government orders restricted the restaurants’ use of and access to their property, resulting in the suspension of their operations and the loss of income. In reaching this holding, the Supreme Court of North Carolina joined the Supreme Court of Vermont as the only other state supreme court to have ruled in favor of policyholders on the question of COVID-19 business interruption insurance coverage.
Healthcare & Life Sciences Private Equity Deal Tracker: Whistler Capital Invests in GXP-Storage
Whistler Capital Partners has invested in GXP-Storage, according to a news release.
GXP, based in Middlesex, North Carolina, is provider of regulated material management solutions for regulated life sciences research, manufacturing and healthcare.
Whistler Capital, founded in 2021 and based in Nashville, is private equity firm focused on growth equity and growth…
Growing a Pure-Play Med Spa,With Alyssa Rapp and Logan Pitts
Med spas rapidly are becoming the front door to healthcare, and Empower Aesthetics has put out the welcome mat. Partnering with financial sponsor Shore Capital, Empower’s platform of medical spas are located in Texas and Tennessee and building in the Midwest and upstate New York.
With McGuireWoods partner and host Geoff Cockrell,…
Healthcare & Life Sciences Private Equity Deal Tracker: 3 Boomerang Invests in Enjoin
3 Boomerang Capital has announced a majority growth investment in Enjoin.
Enjoin, founded in 1988 and based in Collierville, Tennessee, provides clinical documentation integrity solutions for hospitals and health systems.
3 Boomerang, based in Greenwich, Conn., invests in lower middle market healthcare companies in North America and Western Europe. Founded in 2023, the…
Valeas Capital Closes First Fund at $600 Million
Valeas Capital Partners has announced the closing of its first institutional fund at more than $600 million.
The inaugural fund, VCP Fund I, exceeded its target.
Valeas, founded in 2021 and based in San Francisco, is a middle-market, growth-buyout private equity firm. The firm prefers to invest between $50 million and $150 million in companies…
Recent Decision from Eastern District of New York Confirms D&O Coverage for False Claims Act Defense Costs
A recent decision by a federal court in the Eastern District of New York illustrates how directors and officers (“D&O”) policies can provide valuable insurance coverage for defense costs and potential liabilities arising from False Claims Act (“FCA”) litigation. In Northern Metropolitan Foundation for Healthcare, Inc. v. RSUI Indemnity Company, Case No. 20-CV-2224 (EK)…
Healthcare & Life Sciences Private Equity Deal Tracker: Argosy Invests in Nicklas Medical Staffing
Argosy Healthcare Partners (AHP) has announced the recapitalization of Nicklas Medical Staffing (NMS).
NMS, founded in 2013 and based in Jacksonville, Florida, provides staffing solutions for pathology and histology labs.
AHP, based in Wayne, Pennsylvania, is a lower middle market private equity investor focused exclusively on healthcare. A division of Argosy Capital, AHP…
Healthcare & Life Sciences Private Equity Deal Tracker: Ampersand Acquires Nektar Therapeutics’ PEGylation
By Kevin Madagan
Ampersand Capital Partners has announced its acquisition of Nektar Therapeutics’ PEGylation reagent manufacturing business.
The business, which will be branded Gannet BioChem and continue to operate out of its facility in Huntsville, Alabama, develops, scales and manufactures polyethylene glycol (PEG) reagents, which are used in advanced biopharmaceutical and therapeutic products.